These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31294323)

  • 1. Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism.
    Klok FA; Presles E; Tromeur C; Barco S; Konstantinides SV; Sanchez O; Pernod G; Raj L; Robin P; Le Roux PY; Hoffman C; Mélac S; Bertoletti L; Girard P; Laporte S; Mismetti P; Meyer G; Leroyer C; Couturaud F;
    Res Pract Thromb Haemost; 2019 Jul; 3(3):364-371. PubMed ID: 31294323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.
    Klok FA; Barco S; Turpie AGG; Haas S; Kreutz R; Mantovani LG; Gebel M; Herpers M; Bugge JP; Kostantinides SV; Ageno W
    Br J Haematol; 2018 Nov; 183(3):457-465. PubMed ID: 30123981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism.
    Klok FA; Barco S; Konstantinides SV
    Thromb Haemost; 2017 Jun; 117(6):1164-1170. PubMed ID: 28276566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
    Robertson L; Yeoh SE; Ramli A
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
    Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
    J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of bleeding events using the VTE-BLEED risk score in patients with venous thromboembolism receiving anticoagulant therapy (Review).
    Badescu MC; Ciocoiu M; Badulescu OV; Vladeanu MC; Bojan IB; Vlad CE; Rezus C
    Exp Ther Med; 2021 Nov; 22(5):1344. PubMed ID: 34630698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
    Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Shi M; Thavorn K; Hutton B; Le Gal G; Rodger M; Fergusson D
    J Thromb Haemost; 2021 Nov; 19(11):2801-2813. PubMed ID: 34379859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m).
    Marshall A; Levine M; Hill C; Hale D; Thirlwall J; Wilkie V; French K; Kakkar A; Lokare A; Maraveyas A; Chapman O; Arif A; Petrou S; Maredza M; Hobbs R; Dunn JA; Young AM
    J Thromb Haemost; 2020 Apr; 18(4):905-915. PubMed ID: 31995662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial].
    Couturaud F; Pernod G; Pison C; Mismetti P; Sanchez O; Meyer G; Parent F; Girard P; Simonneau G; Drouet L; Gueret P; Jego P; Delaval P; Duhamel E; Gruel Y; Delahousse B; Regina S; Pottier P; Connaud J; Lecomte F; Provost K; Vilmans N; Gosset X; Bura-Rivière A; Meach G; Lacut K; Bosson JL; Guillot K; Mottier D; Leroyer C
    Rev Mal Respir; 2008 Sep; 25(7):885-93. PubMed ID: 18946418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of DVT: how long is enough and how do you predict recurrence.
    Agnelli G; Becattini C
    J Thromb Thrombolysis; 2008 Feb; 25(1):37-44. PubMed ID: 17906973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
    Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
    J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the VTE-BLEED score's long-term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry.
    Nishimoto Y; Yamashita Y; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    J Thromb Haemost; 2020 Mar; 18(3):624-632. PubMed ID: 31785073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial.
    Raj L; Presles E; Le Mao R; Robin P; Sanchez O; Pernod G; Bertoletti L; Jego P; Lemarié CA; Leven F; Hoffmann C; Planquette B; Le Roux PY; Slaun PY; Nonent M; Girard P; Lacut K; Mélac S; Guégan M; Mismetti P; Laporte S; Meyer G; Leroyer C; Tromeur C; Couturaud F;
    Am J Med; 2020 Aug; 133(8):e406-e421. PubMed ID: 32333853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
    Palareti G; Legnani C; Antonucci E; Cosmi B; Falanga A; Poli D; Mastroiacovo D; Pengo V; Ageno W; Testa S
    Ther Adv Drug Saf; 2021; 12():20420986211062965. PubMed ID: 34987749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of recurrent venous thromboembolism and bleeding in patients with interstitial lung disease: a cohort study.
    Le Mao R; Ropars T; Tromeur C; Barnier A; Hourmant B; Guegan M; Jimenez D; Leroyer C; Lacut K; Couturaud F
    J Thromb Thrombolysis; 2022 Jan; 53(1):67-73. PubMed ID: 34232453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
    Pawar A; Gagne JJ; Gopalakrishnan C; Iyer G; Tesfaye H; Brill G; Chin K; Bykov K
    JAMA; 2022 Mar; 327(11):1051-1060. PubMed ID: 35289881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
    Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
    Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.